Delivery Order SPE2DB20D1004-SPE2DB22FE9L1
Award Date
12/2/21
Potential Completion Date
12/3/21
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $5,053.11, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 21, 2021. The contract is a firm fixed-price delivery order with a completion date of December 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a...
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,350.60 and was awarded on February 1, 2022, with a completion date of February 2, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $8,729.62 and a completion date of October 20, 2021. The contract was awarded on October 19, 2021, and there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $3,339.00. It has an ultimate completion date of April 15, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $3,326.76 and a completion date of January 26, 2022. The award was made on January 25, 2022, and there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $3,325.95, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
The federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract, valued at $4,965.76, is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the...
This federal contract award is for the delivery of Restasis 0.05% eye emulsion 30s to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $10,105.84 and was awarded on March 10, 2022, with a completion date of March 11, 2022. The contract is a firm fixed-price delivery order, with no set-aside designations. Amerisourcebergen Drug Corp is a...
The federal contract award is for the delivery of Restasis 0.05% eye emulsion to support military and government healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,080.48, was awarded by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award is for the delivery of Restasis 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,482.88 and was awarded on June 6, 2022, with a completion date of June 7, 2022. The contract is a delivery order with a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...